UroGen Pharma URGN Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $110.75M-35.6% | $171.99M+81.0% | $95M+71.5% | $55.41M+24.9% | ||
| $9.71M-85.0% | $64.7M+54.2% | $41.97M-5.8% | $44.56M-0.5% | ||
| $1.35M+25.5% | $1.08M+31.1% | $821K+1.0% | $813K-33.7% | ||
| $33.08M+62.9% | $20.3M+31.5% | $15.44M+21.6% | $12.7M+8.4% | ||
| $16.46M+78.4% | $9.23M+62.6% | $5.67M+31.2% | $4.33M-10.5% | ||
| $14.67M+65.9% | $8.85M-14.0% | $10.28M-7.4% | $11.1M+48.5% | ||
| $186.02M-32.6% | $276.14M+63.2% | $169.19M+31.2% | $128.91M+12.7% | ||
| $637K-2.7% | $655K-4.9% | $689K-46.9% | $1.3M-34.1% | ||
| $5.16M+776% | $589K-71.1% | $2.04M-25.6% | $2.74M+109% | ||
| $200.46M-29.8% | $285.71M+60.2% | $178.31M+31.5% | $135.62M+13.3% | ||
| $27.72M+1.0% | $27.43M+65.9% | $16.54M+33.6% | $12.38M+2.3% | ||
| $13.52M+27.9% | $10.57M-2.3% | $10.81M+31.0% | $8.26M+18.8% | ||
| $481K-38.7% | $785K-4.2% | $819K-67.6% | $2.53M+69.9% | ||
| $1.27M+71.0% | $745K— | $0— | —— | ||
| $15.28M+14.2% | $13.37M+9.2% | $12.25M+6.1% | $11.54M+5.0% | ||
| $46.42M+1.0% | $45.95M+47.2% | $31.21M+30.5% | $23.92M+6.9% | ||
| $122.21M+0.4% | $121.73M+23.5% | $98.55M+1.0% | $97.54M— | ||
| $4.75M+103% | $2.34M— | —— | —— | ||
| $3.13M+121% | $1.42M-14.9% | $1.66M-34.2% | $2.53M+69.9% | ||
| $3.48M+118% | $1.6M+89.0% | $844K— | —— | ||
| $305.93M+3.9% | $294.51M+20.9% | $243.52M+8.2% | $224.98M+102% | ||
| $133K+15.7% | $115K+29.2% | $89K+41.3% | $63K+3.3% | ||
| $854.09M+7.1% | $797.25M+29.8% | $614.04M+25.9% | $487.79M+2.5% | ||
| -$959.72M-19.0% | -$806.22M-18.7% | -$679.35M-17.7% | -$577.1M-23.5% | ||
| $19K-66.1% | $56K+367% | $12K+111% | -$107K-328% | ||
| -$105.47M-1,098% | -$8.8M+86.5% | -$65.21M+27.0% | -$89.36M-1,162% | ||
| $200.46M-29.8% | $285.71M+60.2% | $178.31M+31.5% | $135.62M+13.3% | ||
| $9.71M-85.0% | $64.7M+54.2% | $41.97M-5.8% | $44.56M-0.5% | ||
| $5.16M+776% | $589K-71.1% | $2.04M-25.6% | $2.74M+109% | ||
| $5.16M+776% | $589K-71.1% | $2.04M-25.6% | $2.74M+109% | ||
| $5.16M+776% | $589K-71.1% | $2.04M-25.6% | $2.74M+109% | ||
| $13.52M+27.9% | $10.57M-2.3% | $10.81M+31.0% | $8.26M+18.8% | ||
| $27.72M+1.0% | $27.43M+65.9% | $16.54M+33.6% | $12.38M+2.3% | ||
| $13.52M+27.9% | $10.57M-2.3% | $10.81M+31.0% | $8.26M+18.8% | ||
| $5.19M-34.8% | $7.95M+106% | $3.86M+17.8% | $3.28M-1.6% | ||
| $3.9M+3.0% | $3.79M+18.7% | $3.19M+5.8% | $3.02M+6.2% | ||
| $130.09M+3.7% | $125.49M+24.2% | $101.06M+1.0% | $100.06M+6,629% | ||
| $854.09M+7.1% | $797.25M+29.8% | $614.04M+25.9% | $487.79M+2.5% | ||
| $133K+15.7% | $115K+29.2% | $89K+41.3% | $63K+3.3% | ||
| $1.27M+71.0% | $745K— | $0— | —— | ||
| $6.12M+270% | $1.65M+95.9% | $844K— | —— | ||
| $127.28M+4.9% | $121.39M+10.6% | $109.72M+10.9% | $98.92M+15.4% | ||
| $177K+0.6% | $176K-21.8% | $225K+0.9% | $223K0.0% | ||
| $8.46M+170% | $3.13M+87.6% | $1.67M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are UroGen Pharma's total assets?
- UroGen Pharma (URGN) holds $253.7M in total assets, up 2.5% year over year.
- How much debt does UroGen Pharma have?
- UroGen Pharma carries $197.1M in total debt against -$124.3M of shareholders' equity, a debt-to-equity ratio of 4.81.
- How much cash does UroGen Pharma have?
- UroGen Pharma holds $110.0M in cash and equivalents.
- Can UroGen Pharma cover its short-term obligations?
- Its current ratio is 4.69 — current assets exceed current liabilities.
- Where does UroGen Pharma's balance sheet data come from?
- Every line is extracted from UroGen Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
